Mindray Acquires Controlling Stake in Shanghai Company
By LabMedica International staff writers Posted on 10 Mar 2014 |
Mindray Shenzhen (China) has reached an equity transfer agreement with Long Island Biotec. Co., Ltd. (Long Island; Shanghai, China) through which Mindray will acquire a controlling stake in the company. Mindray will gain sales capabilities in thrombotic and hemostatic products and the deal will help the company meet market needs for surgery screening tests and detection of cardiovascular disease.
After the share transfer, Long Island will benefit from Mindray’s well-established R&D, engineering, production, sales, and marketing platforms, as well as its overall management. By combining Long Island’s strength in the field of thrombotic and hemostatic reagent products and Mindray’s advantages as a medical equipment maker, Long Island will raise the quality of both products and customer services. The combined company will broaden development opportunities for employees, and help Long Island establish a stronger position to compete in the marketplace.
Mindray develops, manufactures, and markets medical devices worldwide. The global headquarters are in China and the US headquarters are in Mahwah (NJ, USA). The company supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems.
Related Links:
Mindray
Long Island Biotec
After the share transfer, Long Island will benefit from Mindray’s well-established R&D, engineering, production, sales, and marketing platforms, as well as its overall management. By combining Long Island’s strength in the field of thrombotic and hemostatic reagent products and Mindray’s advantages as a medical equipment maker, Long Island will raise the quality of both products and customer services. The combined company will broaden development opportunities for employees, and help Long Island establish a stronger position to compete in the marketplace.
Mindray develops, manufactures, and markets medical devices worldwide. The global headquarters are in China and the US headquarters are in Mahwah (NJ, USA). The company supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems.
Related Links:
Mindray
Long Island Biotec
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance